CVS to limit opioid prescriptions to Seven days

CVS to limit opioid prescriptions to Seven days

Pharmacy giant CVS announced on Friday that it would limit the number of opioid prescriptions to seven days for certain health conditions. The new restriction, which will apply to patients new to pain therapy, is part of the company’s effort to help tackle the deadly crisis of opioid addiction in the United States.

In addition, it will limit the daily dosage of pain medication based on their strength. It will also require use of immediate-release formulations prior to extended-release opioids are dispensed.

Larry J. Merlo, Chief Executive of CVS Health, said, “With a presence in nearly 10,000 communities across the country, we see firsthand the impact of the alarming and rapidly growing epidemic of opioid addiction and misuse.”

The new regulation is scheduled to roll out on 1st of February and cover all commercial, health plan, and employer as well as Medicaid clients.

CVS, which operates nearly 9,600 pharmacy stores and 1,100 walk-in medical clinics, manages medications for as many as 90 million plan members in the United States.